Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹293 Cr₹222 Cr₹192 Cr₹205 Cr₹216 Cr

What is the latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹293 Cr based on Mar2025 Consolidated results.
Year Sundry Debtors
Mar2025₹293 Cr
Mar2024₹222 Cr
Mar2023₹192 Cr
Mar2022₹205 Cr
Mar2021₹216 Cr

How is Sundry Debtors of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2025 ₹293 Cr
31.75
Mar2024 ₹222 Cr
15.43
Mar2023 ₹192 Cr
-6.27
Mar2022 ₹205 Cr
-4.81
Mar2021 ₹216 Cr -

Compare Sundry Debtors of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹41,386.1 Cr 1.5% -1.6% 21.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,439.0 Cr 5.7% -3.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹162,903.0 Cr 1.6% -7.6% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,466.0 Cr -0.5% 0.9% 23.6% Stock Analytics
CIPLA ₹107,653.0 Cr 0.5% -12.9% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,924.0 Cr 5.3% -0.9% 1.9% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

1.5%

-1.6%

21.8%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses